Picture Not Available

Robert W. Mason, PhD

Contact Dr. Mason


,


Most Recent Peer-reviewed Publications

  1. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II
  2. Development of bone targeting drugs
  3. Epidemiology of mucopolysaccharidoses
  4. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII
  5. Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
  6. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia
  7. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses
  8. Gene therapy for Mucopolysaccharidoses
  9. Mucopolysaccharidosis IVA and glycosaminoglycans
  10. Glycosaminoglycans detection methods: Applications of mass spectrometry
  11. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry
  12. Current therapies for Morquio A syndrome and their clinical outcomes
  13. Activity of daily living for Morquio A syndrome
  14. Cathepsin inhibition prevents autophagic protein turnover and downregulates insulin growth factor-1 receptor-mediated signaling in neuroblastoma
  15. Stability of furosemide and chlorothiazide stored in syringes
  16. Non-invasive pulmonary function test on Morquio patients
  17. Chondroitin and keratan sulfate
  18. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with morquio a syndrome
  19. Therapies for the bone in mucopolysaccharidoses
  20. Activities of daily living in patients with Hunter syndrome: Impact of enzyme replacement therapy and hematopoietic stem cell transplantation